Vincristine (V), dactinomycin (A), and lower doses of cyclophosphamide (C) with or without radiation therapy for patients with newly diagnosed low-risk embryonal rhabdomyosarcoma (ERMS): A report from the Children’s Oncology Group (COG).
David Walterhouse
No relevant relationships to disclose
Alberto S. Pappo
No relevant relationships to disclose
Jane L Meza
No relevant relationships to disclose
John C. Breneman
No relevant relationships to disclose
Andrea Anita Hayes-Jordan
No relevant relationships to disclose
David Parham
No relevant relationships to disclose
Timothy P Cripe
No relevant relationships to disclose
William H. Meyer
Research Funding - Children's Oncology Group
Douglas S. Hawkins
Research Funding - Children's Oncology Group